2 results
Approved WMORecruitment stopped
The objective of this study is to compare the efficacy of Infliximab-biosimilar to Infliximab-innovator and to demonstrate its noninferiority up to 30 weeks, in patients with ulcerative colitis or Crohn*s disease in remission under treatment with…
Approved WMOWill not start
To compare the outcome of endoluminal fundoplication with Esophyx* to laparoscopic Nissen fundoplication for GERD in selected patient population.